-
FDA Drug Safety Concerns About Pradaxa And Serious Bleeding Side Effects Will Get Another Look By Means Of New 2014 Study
A Primary Focus Is Gastrointestinal And Intracranial Hemorrhages In Patients Using Pradaxa For Atrial Fibrillation (Posted by Tom Lamb at DrugInjuryWatch.com)Pradaxa, an anticoagulant drug from Boehringer Ingelheim, was approved by drug regulators in Europe…
-
The Association Of Antipsychotic Drug Risperdal (Risperidone) With Gynecomastia / Male Breasts Side Effect Is Subject Of Pharmaceutical Litigation Against Janssen
Legal Issue In These Risperdal Lawsuits Is Whether The Drug Label Provided Timely And Sufficient Warning About The Development Of Breasts In Boys And Men (Posted by Tom Lamb at DrugInjuryWatch.com)Gynecomastia is swelling of…
-
Pfizer’s Lipitor Statin Drug For Treatment Of High Cholesterol Linked To An Increased Risk Of Type-2 Diabetes In Some Older And Post-Menopausal Women
February 2012 FDA Drug Safety Warning About Lipitor Label Change Concerning New-Onset Diabetes Mellitus (DM) Has Gone Largely Unnoticed To Date (Posted by Tom Lamb at DrugInjuryWatch.com)Statins are a class of prescription drugs used…
-
September 2013 NuvaRing Update By Merck Reveals More Than 1,700 Lawsuits Filed Since This Products Liability Litigation Started In 2007
Serious Injury And Death Cases Involve Blood Clots Leading To DVT And/Or PE Events As Well As Heart Attacks And Strokes In Women Of Various Ages (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE:"Merck to…
-
During 2013 Bayer Has Had More Than 2000 YAZ / Yasmin Lawsuits For Blood Clots That Are Not Settled
September 2013 Bayer Corporate Report Shows Apparent Progress In Settlement Negotiations, But A Number Of More Serious Cases Are Still Pending (Posted by Tom Lamb at DrugInjuryWatch.com) According to Bayer corporate reports, the number of unsettled…
